Anteris Technologies Global Corp. reported $2.2M of revenue over the trailing twelve months, −9.6% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.2M (to Q2 2026). Net income: −$104M, trailing twelve months to Q2 2026. Free cash flow: −$88M, trailing twelve months to Q2 2026. Operating margin: −5616%, trailing twelve months to Q2 2026.

AVRAnteris Technologies Global Corp.

Healthcare

$6.63+52% 1Y

$6.63

$3.3852 weeks$10.57

AVR as reported

Anteris Technologies Global Corp. reported $2.2M of revenue over the trailing twelve months, −9.6% on the year before. 10 reported series are charted on this page, each one as filed.

$2.2M

Revenue, trailing twelve months · to Q2 2026 · −9.6% against the twelve months before

Net income: −$104M
Net income · +23% year on year · trailing twelve months to Q2 2026
Free cash flow: −$88M
Free cash flow · +18% year on year · trailing twelve months to Q2 2026
Operating margin: −5616%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for AVR, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.2M	−9.6%	Q2 2026
Net income	−$104M	+23%	Q2 2026
EPS	−$1.95	−34%	Q2 2026
Gross margin	74%	n/a	Q2 2026
Operating margin	−5616%	n/a	Q2 2026
Net margin	−5537%	n/a	Q2 2026
ROE	24719%	n/a	Q2 2026
ROA	−230%	n/a	Q2 2026
ROIC	1171%	n/a	Q2 2026
Free cash flow	−$88M	+18%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.